The overall purpose of this study is the assessment of treatment outcome among traumatized patients seeking individual and/or group therapy at the Victims of Violence Program. The study gathers information from patients using quantitative (self-report) and qualititative (interview-based) approaches, to determine changes in symptom patterns and domains of functioning relevant to psychological trauma.

Condition	Intervention	Phase
Posttraumatic Stress Disorders	Behavior: Individual therapy  Behavior: Group therapy	Phase II

Further Study Details: 

Expected Total Enrollment:  1000

The focus of the Trauma Recovery and Resiliency Project is the evaluation of treatment outcome among complexly traumatized patients seeking individual and/or group therapy at the Victims of Violence (VOV) Program, a specialty clinic located in the Outpatient Psychiatry Department of the Cambridge Health Alliance and affiliated with Harvard Medical School. The project has two major components: (1) All patients seeking VOV treatment are administered a battery of self-report measures assessing symptoms associated with complex trauma (i.e., interpersonal trauma that is usually repeated and prolonged) (2) A subsample of patients are interviewed using the Multidimensional Trauma Recovery and Resiliency Interview (MTRRI) and its companion rating scale (MTRR; Harvey et al, 1994, 2000, 2003) to assess trauma impact, recovery and resiliency on eight domains of psychological functioning. Data is analyzed using quantitative and qualitative approaches to evaluate treatment effectiveness and elucidate the recovery trajectories of patients receiving VOV treatment.

Ages Eligible for Study:  18 Years   -   65 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• In individual or group therapy at VOV program
• Consents to research participation

Exclusion Criteria:

• Insufficient proficiency in English to complete self-report measures and/or interview
• Research participation clinically counterindicated

Please refer to this study by ClinicalTrials.gov identifier  NCT00131534

Michaela Mendelsohn, Ph.D.      (617) 575-5283    mmendelsohn@challiance.org
Kelley Callahan, Ph.D.      (617) 575-5314    kcallahan@challiance.org

Massachusetts
      Victims of Violence Program, Cambridge Health Alliance, Somerville,  Massachusetts,  02143,  United States; Recruiting

Study chairs or principal investigators

Mary R. Harvey, Ph.D.,  Principal Investigator,  Victims of Violence Program, Cambridge Health Alliance   
Judith L. Herman, MD,  Principal Investigator,  Victims of Violence Program, Cambridge Health Alliance   

Study ID Numbers:  CHA-IRB-0031/01/04
Last Updated:  August 17, 2005
Record first received:  August 16, 2005
ClinicalTrials.gov Identifier:  NCT00131534
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-08-23